CD28 and neoplasm: In an orthotopic mouse model of pleural mesothelioma, high doses of both CD28- and 4-1BB-based second-generation CAR T cells eradicated tumors effectively, whereas PD-1 upregulation in the tumor microenvironment inhibited T cell function.